C50 |
---|
GCTGATCAACCCTACATGTGTAGGTAACCCTAACCCTAACCCTAAGGACA |
C55 |
GCTGATCAACCCTACATGTGTAGGTAACCCTAACCCTAACCCTAAGGACAACCCT |
C60 |
GCTGATCAACCCTACATGTGTAGGTAACCCTAACCCTAACCCTAAGGACAACCC-TAGTGA |
C65 |
GCTGATCAACCCTACATGTGTAGGTAACCCTAACCCTAACCCTAAGGACAACCCTAGTGAAGCTT |
C70 |
GCTGATCAACCCTACATGTGTAGGTAACCCTAACCCTAACCCTAAGGACAACCCTAGTGAAGCTTGTAAC |
G24 2 |
CCTACACATGTAGGGTTGATCAGC |
G30 |
GGGTTACCTACACATGTAGGGTTGATCAGC |
G35 |
GGTTAGGGTTACCTACACATGTAGGGTTGATCAGC |
G40 |
GTTAGGGTTAGGGTTACCTACACATGTAGGGTTGATCAGC |
G45 |
TTAGGGTTAGGGTTAGGGTTACCTACACATGTAGGGTTGATCAGC |
G80 |
CTTCACAGTCAGAGTCACAGTGTGCCGGGTTGTCCTTAGGGTTAGGGTTAGGGTTACCTACACATGTAGGGTTGATCAGC |
1All sequences are depicted in 5' to 3' orientation. 2For EMSA on single-stranded G24, G30, G35, G40, G45. and G80, each oligomer included a 3'-PO4 moiety to block WRN exonuclease activity; overhang substrates were constructed with G45 with a 3' PO4 group, also to block potential WRN exonuclease activity on the unlabeled strand. |